3 ML insulin glargine-yfgn 100 UNT/ML Pen Injector [Semglee]

Verify with CMS →

insulin glargine-yfgn

RxCUI: 2563973

Important: Drug coverage and costs vary by plan and location. Verify coverage directly with your Medicare plan before filling a prescription. This is informational data only and should not replace advice from your healthcare provider or pharmacist.
0.1%
Plan Coverage
3
Plans Covering
T2
Avg Tier
0%
Prior Auth Required

What the CMS Formulary Data Shows for 3 ML insulin glargine-yfgn 100 UNT/ML Pen Injector [Semglee]

Per the CMS 2026 Part D formulary file, 3 ML insulin glargine-yfgn 100 UNT/ML Pen Injector [Semglee] (RxNorm concept RXCUI 2563973, generic name insulin glargine-yfgn) appears on 2 distinct formulary files spanning 3 Medicare Part D plan offerings - 0.1% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 3, with a cross-plan average of Tier 2.

Real-world access to 3 ML insulin glargine-yfgn 100 UNT/ML Pen Injector [Semglee] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 50% apply quantity limits.

Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 3 ML insulin glargine-yfgn 100 UNT/ML Pen Injector [Semglee] today.

Coverage Details

Formularies covering
2
Plans covering
3
Coverage rate
0.1%
Tier range
Tier 1 – Tier 3
Average tier
Tier 2, Generic

Restrictions

Prior authorization required
0% of formularies
Step therapy required
0% of formularies
Quantity limits
50% of formularies

Tier Distribution Across Plans

2 plans
Tier 1, Preferred Generic
1 plans
Tier 3, Preferred Brand

Medicare Advantage Plans (MA-PD) Covering 3 ML insulin glargine-yfgn 100 UNT/ML Pen Injector [Semglee]

3 Medicare Advantage plans with Part D drug coverage include this drug.

Plan Insurer Tier PA Premium States
CCA One Care (HMO D-SNP) COMMONWEALTH CARE ALLIANCE, INC. T1 No $0 MA
CCA Senior Care Options (HMO D-SNP) COMMONWEALTH CARE ALLIANCE, INC. T1 No $0 MA
Mass Advantage Extra (PPO) CENTRAL MASS HEALTH, LLC T3 No $0 MA

Frequently Asked Questions

Is 3 ML insulin glargine-yfgn 100 UNT/ML Pen Injector [Semglee] covered by Medicare Part D?

Yes, 3 ML insulin glargine-yfgn 100 UNT/ML Pen Injector [Semglee] is covered by 3 Medicare Part D plans (0.1% of all Part D formularies).

What tier is 3 ML insulin glargine-yfgn 100 UNT/ML Pen Injector [Semglee] on Medicare Part D plans?

3 ML insulin glargine-yfgn 100 UNT/ML Pen Injector [Semglee] averages Tier 2 across Part D plans, ranging from Tier 1 to Tier 3.

Does 3 ML insulin glargine-yfgn 100 UNT/ML Pen Injector [Semglee] require prior authorization?

0% of Part D formularies require prior authorization for 3 ML insulin glargine-yfgn 100 UNT/ML Pen Injector [Semglee]. Step therapy: 0%. Quantity limits: 50%.

Data sourced from the Centers for Medicare & Medicaid Services (CMS). See our methodology for details. Retrieved and formatted by PlainMedicare Editorial